All PlansCoverageMedium impact
Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions
Blue Cross & Blue Shield of Mississippi·MS · Pulmonology, Pediatrics, Family Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
New medical policy establishes coverage criteria for oscillatory devices used to treat cystic fibrosis and chronic diffuse bronchiectasis. High-frequency chest wall compression devices are considered medically necessary only when standard chest physical therapy has failed or is unavailable, while oscillatory positive expiratory pressure devices are covered for patients with hypersecretory lung disease who have difficulty clearing secretions.
Action Required
Immediately: Billing team must ensure proper documentation of medical necessity for oscillatory device claims. Verify that standard chest physical therapy has failed or is unavailable before billing for high-frequency chest wall compression devices. For chronic diffuse bronchiectasis cases, confirm diagnosis with high-resolution or spiral chest CT scan and document daily productive cough for 6+ months or 2+ exacerbations per year requiring antibiotics. Claims without proper medical necessity documentation will be denied.